EU Seeks Suggestions On How To Improve Pediatric & Orphan Drugs Legislation
‘Unmet Need’ And Incentives/Rewards Under The Microscope
Companies wanting to get involved in long-running plans to overhaul the EU orphan drugs and pediatric medicine legislation can make their contribution through a public consultation that began on 10 May.